Please enable JavaScript to continue using this application.

Compare $CRDF vs $SERA | Chartloom

Compare

$CRDF vs $SERA

Cardiff Oncology Inc · Sera Prognostics Inc

CRDF

Cardiff Oncology Inc

SERA

Sera Prognostics Inc

Compare $CRDF vs $SERA

Comparing Cardiff Oncology Inc and Sera Prognostics Inc

CRDFCardiff Oncology Inc

SERASera Prognostics Inc

CRDFCardiff Oncology Inc

Market cap

$84M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

244.08x

Rev growth (TTM)

-7.0%

YTD performance

-59.4%

52W performance

-54.6%

FCF yield

-48.7%

SERASera Prognostics Inc

Market cap

$80M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

89.94x

Rev growth (TTM)

-35.2%

YTD performance

-32.0%

52W performance

-35.2%

FCF yield

-35.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRDF

SERA

Detailed metrics comparison

CRDF

Cardiff Oncology Inc

SERA

Sera Prognostics Inc

Market Cap

CRDF$84M

SERA$80M

Enterprise Value

CRDF$75M

SERA$75M

Price

CRDF$1.08

SERA$2.04

P/E Ratio

CRDFN/A

SERAN/A

P/S Ratio

CRDF165.40x

SERA1,141.23x

EV/Sales

CRDF147.30x

SERA1,078.41x

EV/EBITDA

CRDF0.00x

SERA0.00x

P/B Ratio

CRDF3.28x

SERA1.39x

P/FCF Ratio

CRDFN/A

SERAN/A

EV/FCF

CRDF-1.83x

SERA-2.68x

PEG Ratio

CRDFN/A

SERAN/A

Forward P/E (NTM)

CRDFN/A

SERAN/A

Forward P/S (NTM)

CRDF244.08x

SERA89.94x

Revenue (TTM)

CRDF$508K

SERA$70K

Revenue Growth (YoY)

CRDF-7.0%

SERA-35.2%

Forward Rev Growth

CRDF-19.6%

SERA791.9%

Gross Margin (TTM)

CRDF100.0%

SERA-150.0%

Operating Margin (TTM)

CRDF0.0%

SERA0.0%

EBITDA Margin (TTM)

CRDF-8251.0%

SERA-50200.0%

Net Margin (TTM)

CRDF-7889.0%

SERA-47475.7%

FCF Margin (TTM)

CRDF-8054.3%

SERA-40262.9%

Net Income (TTM)

CRDF$-40M

SERA$-33M

FCF (TTM)

CRDF$-41M

SERA$-28M

EPS (TTM)

CRDF-$0.59

SERA-$0.66

ROE (TTM)

CRDF-10308.0%

SERA-4671.0%

ROA (TTM)

CRDF-7551.0%

SERA-3406.0%

ROIC (TTM)

CRDF-10308.0%

SERA-4671.0%

Cash

CRDF$9M

SERA$4M

Debt

CRDF$0

SERA$0

Net Cash/Debt

CRDF$9M

SERA$4M

Current Ratio (TTM)

CRDF3.30x

SERA1.98x

Quick Ratio (TTM)

CRDF3.21x

SERA1.91x

Debt/Equity (TTM)

CRDF0.00x

SERA0.00x

Debt/Assets (TTM)

CRDF0.0%

SERA0.0%

Interest Coverage (TTM)

CRDFN/A

SERAN/A

Net Debt/EBITDA (TTM)

CRDF0.00x

SERA0.00x

Beta

CRDF1.49

SERA1.09

52W Performance

CRDF-54.6%

SERA-35.2%

YTD Performance

CRDF-59.4%

SERA-32.0%

% from 52W High

CRDF-67.4%

SERA-48.4%

% from 52W Low

CRDF42.7%

SERA30.8%

Asset Turnover (TTM)

CRDF0.01x

SERA0.00x

FCF Yield (TTM)

CRDF-48.7%

SERA-35.3%

Earnings Yield (TTM)

CRDF-47.7%

SERA-41.6%

Dividend Yield (TTM)

CRDFN/A

SERAN/A

Rule of 40

CRDF-8,061.3

SERA-40,298.0

EV/GP/RG

CRDFN/A

SERAN/A

Ticker research

View CRDF research View SERA research

Metric	CRDF Cardiff Oncology Inc	SERA Sera Prognostics Inc
Market & Valuation
Market Cap	$84M	$80M
Enterprise Value	$75M	$75M
Price	$1.08	$2.04
P/E Ratio	N/A	N/A
P/S Ratio	165.40x	1,141.23x
EV/Sales	147.30x	1,078.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.28x	1.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.83x	-2.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	244.08x	89.94x
Revenue & Growth
Revenue (TTM)	$508K	$70K
Revenue Growth (YoY)	-7.0%	-35.2%
Forward Rev Growth	-19.6%	791.9%
Profitability
Gross Margin (TTM)	100.0%	-150.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-8251.0%	-50200.0%
Net Margin (TTM)	-7889.0%	-47475.7%
FCF Margin (TTM)	-8054.3%	-40262.9%
Net Income (TTM)	$-40M	$-33M
FCF (TTM)	$-41M	$-28M
EPS (TTM)	-$0.59	-$0.66
ROE (TTM)	-10308.0%	-4671.0%
ROA (TTM)	-7551.0%	-3406.0%
ROIC (TTM)	-10308.0%	-4671.0%
Financial Health
Cash	$9M	$4M
Debt	$0	$0
Net Cash/Debt	$9M	$4M
Current Ratio (TTM)	3.30x	1.98x
Quick Ratio (TTM)	3.21x	1.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.49	1.09
52W Performance	-54.6%	-35.2%
YTD Performance	-59.4%	-32.0%
% from 52W High	-67.4%	-48.4%
% from 52W Low	42.7%	30.8%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-48.7%	-35.3%
Earnings Yield (TTM)	-47.7%	-41.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,061.3	-40,298.0
EV/GP/RG	N/A	N/A
Ticker research	View CRDF research	View SERA research

Valuation

P/S Ratio

CRDF

165.40x

SERA

1,141.23x

EV/FCF

SERA

-2.68x

CRDF

-1.83x

Growth & revenue

Revenue Growth TTM

CRDF

-7.0%

SERA

-35.2%

Forward Revenue Growth

SERA

791.9%

CRDF

-19.6%

Profitability & performance

Gross Margin

CRDF

100.0%

SERA

-150.0%

ROE

SERA

-4671.0%

CRDF

-10308.0%

FCF Yield %

SERA

-35.3%

CRDF

-48.7%

52-Week Performance

SERA

-35.2%

CRDF

-54.6%

Detailed metrics comparison

CRDF

Cardiff Oncology Inc

SERA

Sera Prognostics Inc

Market Cap

CRDF$84M

SERA$80M

Enterprise Value

CRDF$75M

SERA$75M

Price

CRDF$1.08

SERA$2.04

P/E Ratio

CRDFN/A

SERAN/A

P/S Ratio

CRDF165.40x

SERA1,141.23x

EV/Sales

CRDF147.30x

SERA1,078.41x

EV/EBITDA

CRDF0.00x

SERA0.00x

P/B Ratio

CRDF3.28x

SERA1.39x

P/FCF Ratio

CRDFN/A

SERAN/A

EV/FCF

CRDF-1.83x

SERA-2.68x

PEG Ratio

CRDFN/A

SERAN/A

Forward P/E (NTM)

CRDFN/A

SERAN/A

Forward P/S (NTM)

CRDF244.08x

SERA89.94x

Revenue (TTM)

CRDF$508K

SERA$70K

Revenue Growth (YoY)

CRDF-7.0%

SERA-35.2%

Forward Rev Growth

CRDF-19.6%

SERA791.9%

Gross Margin (TTM)

CRDF100.0%

SERA-150.0%

Operating Margin (TTM)

CRDF0.0%

SERA0.0%

EBITDA Margin (TTM)

CRDF-8251.0%

SERA-50200.0%

Net Margin (TTM)

CRDF-7889.0%

SERA-47475.7%

FCF Margin (TTM)

CRDF-8054.3%

SERA-40262.9%

Net Income (TTM)

CRDF$-40M

SERA$-33M

FCF (TTM)

CRDF$-41M

SERA$-28M

EPS (TTM)

CRDF-$0.59

SERA-$0.66

ROE (TTM)

CRDF-10308.0%

SERA-4671.0%

ROA (TTM)

CRDF-7551.0%

SERA-3406.0%

ROIC (TTM)

CRDF-10308.0%

SERA-4671.0%

Cash

CRDF$9M

SERA$4M

Debt

CRDF$0

SERA$0

Net Cash/Debt

CRDF$9M

SERA$4M

Current Ratio (TTM)

CRDF3.30x

SERA1.98x

Quick Ratio (TTM)

CRDF3.21x

SERA1.91x

Debt/Equity (TTM)

CRDF0.00x

SERA0.00x

Debt/Assets (TTM)

CRDF0.0%

SERA0.0%

Interest Coverage (TTM)

CRDFN/A

SERAN/A

Net Debt/EBITDA (TTM)

CRDF0.00x

SERA0.00x

Beta

CRDF1.49

SERA1.09

52W Performance

CRDF-54.6%

SERA-35.2%

YTD Performance

CRDF-59.4%

SERA-32.0%

% from 52W High

CRDF-67.4%

SERA-48.4%

% from 52W Low

CRDF42.7%

SERA30.8%

Asset Turnover (TTM)

CRDF0.01x

SERA0.00x

FCF Yield (TTM)

CRDF-48.7%

SERA-35.3%

Earnings Yield (TTM)

CRDF-47.7%

SERA-41.6%

Dividend Yield (TTM)

CRDFN/A

SERAN/A

Rule of 40

CRDF-8,061.3

SERA-40,298.0

EV/GP/RG

CRDFN/A

SERAN/A

Ticker research

View CRDF research View SERA research

Metric	CRDF Cardiff Oncology Inc	SERA Sera Prognostics Inc
Market & Valuation
Market Cap	$84M	$80M
Enterprise Value	$75M	$75M
Price	$1.08	$2.04
P/E Ratio	N/A	N/A
P/S Ratio	165.40x	1,141.23x
EV/Sales	147.30x	1,078.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.28x	1.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.83x	-2.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	244.08x	89.94x
Revenue & Growth
Revenue (TTM)	$508K	$70K
Revenue Growth (YoY)	-7.0%	-35.2%
Forward Rev Growth	-19.6%	791.9%
Profitability
Gross Margin (TTM)	100.0%	-150.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-8251.0%	-50200.0%
Net Margin (TTM)	-7889.0%	-47475.7%
FCF Margin (TTM)	-8054.3%	-40262.9%
Net Income (TTM)	$-40M	$-33M
FCF (TTM)	$-41M	$-28M
EPS (TTM)	-$0.59	-$0.66
ROE (TTM)	-10308.0%	-4671.0%
ROA (TTM)	-7551.0%	-3406.0%
ROIC (TTM)	-10308.0%	-4671.0%
Financial Health
Cash	$9M	$4M
Debt	$0	$0
Net Cash/Debt	$9M	$4M
Current Ratio (TTM)	3.30x	1.98x
Quick Ratio (TTM)	3.21x	1.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.49	1.09
52W Performance	-54.6%	-35.2%
YTD Performance	-59.4%	-32.0%
% from 52W High	-67.4%	-48.4%
% from 52W Low	42.7%	30.8%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-48.7%	-35.3%
Earnings Yield (TTM)	-47.7%	-41.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,061.3	-40,298.0
EV/GP/RG	N/A	N/A
Ticker research	View CRDF research	View SERA research